SCHEMBL20358155

SCHEMBL20358155

CCOC(=O)/C(C#N)=C(/C)c1ccc(OC)c(OC)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.69
ALDH1A1 P00352 5/20 0.55
PKM P14618 1/20 0.55
HTT P42858 1/20 0.55
CYP2C19 P33261 2/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 3/20 0.48
ELANE P08246 1/20 0.48
MAPK1 P28482 1/20 0.48
TSHR P16473 4/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
KDM4E B2RXH2 2/20 0.46
GAA P10253 1/20 0.46
MAPK10 P53779 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20358156 1.00 HPGD (0.69) HPGDALDH1A1PKMHTTCYP2C19
SCHEMBL28671477 0.90 HSD17B2 (0.59) HPGDALDH1A1PKMHTTPOLB
SCHEMBL18078302 0.86 HPGD (0.76) HPGDALDH1A1HTTCYP2C19POLB
SCHEMBL28280523 0.86 HPGD (0.76) HPGDALDH1A1HTTCYP2C19POLB
SCHEMBL11138250 0.84 MAPT (0.46) HPGDALDH1A1POLBMAPTTSHR
SCHEMBL11138252 0.84 MAPT (0.46) HPGDALDH1A1POLBMAPTTSHR
SCHEMBL10610913 0.83 MAPK1 (0.55) HPGDALDH1A1PKMHTTCYP2C19
SCHEMBL10610905 0.83 MAPK1 (0.55) HPGDALDH1A1PKMHTTCYP2C19
SCHEMBL1553877 0.82 CYP19A1 (0.50) HPGDALDH1A1HTTCYP2C19POLB
SCHEMBL2368634 0.82 HPGD (0.46) HPGDALDH1A1PKMHTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723998-B2 Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells NORTHEAST NORMAL UNIVERSITY (CN) 2020-07-28 US claimed
US-20180195039-A1 APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS NORTHEAST NORMAL UNIVERSITY (CN) 2018-07-12 US claimed
US-10723998-B2 Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells NORTHEAST NORMAL UNIVERSITY (CN) 2020-07-28 US disclosed
US-20180195039-A1 APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS NORTHEAST NORMAL UNIVERSITY (CN) 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195039-A1 APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS XPA, MEP1A, EED HPGD 2257/4885ALDH1A1 107/4885PKM 2068/4885
US-10723998-B2 Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells XPA, MEP1A, EED HPGD 2257/4885ALDH1A1 107/4885PKM 2068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.